Physician profile
Jerome Wang
NPI 1326076746
$458.20
in general payments reported to CMS, 2019-2025
11 companies · $225 in 2025
The $225 reported for 2025 was more than what 77% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.58 · 2022: $53.68 · 2024: $140 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $78.99 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $72.76 | 2025 | |
| Glaxosmithkline, LLC. | $51.05 | 2024-2025 | Arexvy, Shingrix, Bexsero |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.34 | 2024-2025 | Jardiance |
| Sanofi Pasteur INC. | $39.48 | 2019-2024 | |
| Lilly USA, LLC | $37.56 | 2024 | Zepbound, Jardiance, Trulicity |
| Merck Sharp & Dohme LLC | $34.00 | 2024 | |
| Mayne Pharma Commercial LLC | $33.43 | 2025 | |
| Verrica Pharmaceuticals INC. | $24.56 | 2025 | Ycanth |
| Janssen Pharmaceuticals, INC | $24.21 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerome Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.